New studies add to body of evidence questioning 340B efficacy

Recent studies add to the growing body of evidence questioning the value of the current 340B program and whether it ’s benefiting patients as Congress intended. 
Source: The Catalyst - Category: Pharmaceuticals Tags: 340B Source Type: news